Skip to content

IO Biotech, Inc.

IOBTQ

CIK 0001865494

← back to feed
Revenue (TTM)
—
Q3 Nov 2025
Net Income (TTM)
−$81.03M
−10.9% YoY Q3 Nov 2025
EPS Diluted (TTM)
−$1.23
+26.8% YoY Q3 Nov 2025
Gross Margin
—
Q3 Nov 2025
Operating Margin
—
Q3 Nov 2025
Net Margin
—
Q3 Nov 2025
Free Cash Flow (TTM)
−$83.84M
Q3 Nov 2025
Cash
$30.66M
Q3 Nov 2025
Total Debt
$16.66M
Q3 Nov 2025
Shares Outstanding
71.95M sh
Q3 Nov 2025

Revenue & Net Income

EPS (Diluted)

Cash Flow

Revenue Growth (YoY)

No data available for this metric.

Balance Sheet

Cash vs Debt

Recent filings